全文获取类型
收费全文 | 2991020篇 |
免费 | 223752篇 |
国内免费 | 6380篇 |
专业分类
耳鼻咽喉 | 41357篇 |
儿科学 | 98863篇 |
妇产科学 | 81818篇 |
基础医学 | 437493篇 |
口腔科学 | 83872篇 |
临床医学 | 272251篇 |
内科学 | 573398篇 |
皮肤病学 | 66717篇 |
神经病学 | 236294篇 |
特种医学 | 113477篇 |
外国民族医学 | 784篇 |
外科学 | 449890篇 |
综合类 | 67909篇 |
现状与发展 | 17篇 |
一般理论 | 1167篇 |
预防医学 | 235399篇 |
眼科学 | 70219篇 |
药学 | 222785篇 |
15篇 | |
中国医学 | 6563篇 |
肿瘤学 | 160864篇 |
出版年
2019年 | 24615篇 |
2018年 | 33952篇 |
2017年 | 25884篇 |
2016年 | 29019篇 |
2015年 | 32854篇 |
2014年 | 46112篇 |
2013年 | 69027篇 |
2012年 | 94164篇 |
2011年 | 100396篇 |
2010年 | 59943篇 |
2009年 | 56326篇 |
2008年 | 93733篇 |
2007年 | 99796篇 |
2006年 | 100738篇 |
2005年 | 97670篇 |
2004年 | 93638篇 |
2003年 | 89972篇 |
2002年 | 86996篇 |
2001年 | 135897篇 |
2000年 | 139251篇 |
1999年 | 116787篇 |
1998年 | 32361篇 |
1997年 | 28360篇 |
1996年 | 28472篇 |
1995年 | 28896篇 |
1994年 | 26652篇 |
1993年 | 25060篇 |
1992年 | 91603篇 |
1991年 | 89658篇 |
1990年 | 87648篇 |
1989年 | 84410篇 |
1988年 | 77467篇 |
1987年 | 76456篇 |
1986年 | 71585篇 |
1985年 | 68843篇 |
1984年 | 51376篇 |
1983年 | 43568篇 |
1982年 | 26027篇 |
1979年 | 47357篇 |
1978年 | 33964篇 |
1977年 | 28322篇 |
1976年 | 27139篇 |
1975年 | 28968篇 |
1974年 | 34971篇 |
1973年 | 33338篇 |
1972年 | 31168篇 |
1971年 | 29490篇 |
1970年 | 27170篇 |
1969年 | 25806篇 |
1968年 | 23745篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
51.
52.
Chopard Romain Campia Umberto Morin Lucas Jering Karola S. Almarzooq Zaid I. Snyder Julia Elizabeth Rizzo Samantha Waxman Aaron B. Goldhaber Samuel Z. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(3):449-460
Journal of Thrombosis and Thrombolysis - Multidisciplinary pulmonary embolism (PE) response teams have garnered widespread adoption given the complexities of managing acute PE and provide a... 相似文献
53.
目的 探讨血液肿瘤患者接受化疗后发生肛周感染的危险因素。方法 采用回顾性病例对照研究的方法,对四川省某三级甲等医院血液内科2020年12月—2021年5月收治的进行化疗的348例血液肿瘤住院患者相关资料(人口学特征、疾病特征、医疗及护理病例记录、实验室检查结果)予以回顾性分析,根据出院诊断发生肛周感染的病例作为病例组,其余病例作为对照组,统计血液肿瘤患者接受化疗后肛周感染的发生率,采用单因素分析和二元Logistic回归分析肛周感染的危险因素。结果 348例血液肿瘤化疗患者,发生肛周感染35例,感染率为10.1%;Logistic回归分析显示,年龄<60岁(OR=8.776,P=0.039)、痔疮史(OR=7.733,P<0.001)、肛周感染史(OR=14.981,P<0.001)、腹泻(OR=3.893,P=0.019)及白细胞计数<1×109/L(OR=6.851,P=0.002)是血液肿瘤患者接受化疗后发生肛周感染的独立危险因素。结论 血液肿瘤患者接受化疗后肛周感染的发生率较高,年龄<60岁、痔疮史、肛周感染史、腹泻、白细胞计数<1×109/L导致血液肿瘤化疗患者肛周感染率增加,在护理化疗期的血液肿瘤患者过程中,应该结合肛周感染的危险因素,采取针对性干预措施,降低肛周感染发生率。 相似文献
54.
Guo Chengyao Yin Shengjie Qiu Kunliang Zhang Mingzhi 《International ophthalmology》2022,42(7):2029-2038
International Ophthalmology - To evaluate and compare the accuracy of six different formulas (Emmetropia Verifying Optical version 2.0, Kane, SRK/T, Barrett Universal II, Haigis and Olsen) in... 相似文献
55.
Cody M. Lebeck Lee MD Ioannis A. Ziogas MD Rajiv Agarwal MD Sophoclis P. Alexopoulos MD Kristen K. Ciombor MD Lea K. Matsuoka MD Daniel B. Brown MD Cathy Eng MD 《Cancer》2022,128(12):2243-2257
The 5-year overall survival rate of a patient with unresectable metastatic colorectal cancer is poor at approximately 14%. Similarly, historical data on liver transplantation (LT) in those with colorectal liver metastases (CRLM) showed poor outcomes, with 5-year survival rates between 12% and 21%. More recently, limited data have shown improved outcomes in select patients with 5-year overall survival rates of approximately 60%. Despite these reported survival improvements, there is no significant improvement in disease-free survival. Given the uncertain benefit with this therapeutic approach and a renewed investigational interest, we aimed to conduct a contemporary systematic review on LT for CRLM. A systematic review of the literature was performed according to the preferred reporting items for systematic reviews and meta-analysis statement. English articles reporting on data regarding LT for CRLM were identified through the MEDLINE (via PubMed), Cochrane Library, and ClinicalTrials.gov databases (last search date: December 16th, 2021) by 2 researchers independently. A total of 58 studies (45 published and 13 ongoing) were included. Although early retrospective studies suggest the possibility that some carefully selected patients may benefit from LT, there is minimal prospective data on the topic and LT remains exploratory in the setting of CRLM. Additionally, several other challenges, such as the limited availability of deceased donor organs and defining appropriate selection criteria, remain when considering the implementation of LT for these patients. Further evidence from ongoing prospective trials is needed to determine if and to what extent there is a role for LT in patients with surgically unresectable CRLM. 相似文献
56.
Edwin van der Pol Joshua A. Welsh Rienk Nieuwland 《Journal of thrombosis and haemostasis》2022,20(1):245-251
The Extracellular Vesicle Flow Cytometry Working Group ( http://www.evflowcytometry.org ) is formed by members of the International Society for Extracellular Vesicles (ISEV), the International Society for Advancement of Cytometry (ISAC), and the International Society on Thrombosis and Haemostasis (ISTH). This working group of flow cytometry experts develops guidelines for best practices regarding flow cytometry detection of extracellular vesicles. To improve rigor and standardization, this working group published a framework outlining the minimal information to report about a flow cytometry experiment on extracellular vesicles (MIFlowCyt-EV) in the Journal of Extracellular Vesicles, the ISEV journal, in 2020. In parallel, an article explaining MIFlowCyt-EV was published in Cytometry Part A, one of the ISAC journals, and now will be introduced to the ISTH as an SSC Communication in the Journal of Thrombosis and Haemostasis. The goal of this SSC Communication is to explain why flow cytometry is becoming the instrument of choice to characterize single extracellular vesicles, the obstacles that have been identified and (mostly) overcome by developing procedures to calibrate flow cytometers, and the relevance of reporting minimal information to improve reliability and reproducibility of experiments in which flow cytometers are used for characterization of extracellular vesicles. 相似文献
57.
Cornelius Anna Pilger Daniel Riechardt Aline Reitemeyer Emanuel Rübsam Anne Winterhalter Sibylle Maier Anna-Karina B. 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(3):957-965
Graefe's Archive for Clinical and Experimental Ophthalmology - To compare the blood flow situation in primary open-angle glaucoma (POAG) and pseudoexfoliation glaucoma (PXG) using optical... 相似文献
58.
Aleodor A Andea 《Histopathology》2022,80(1):150-165
The work-up of melanocytic tumors has undergone significant changes in the last years following the exponential growth of molecular assays. For the practicing pathologist it is often difficult to sort through the myriad of different tests available currently for clinical use. The molecular tests used in melanocytic pathology can be broadly divided into 4 categories: (i) Tests useful in the differential diagnosis of nevus versus melanoma (primarily used as an aid in the diagnosis of histologically ambiguous melanocytic tumors), (ii) Tests that predict prognosis in melanoma, (iii) Tests useful in the classification of melanocytic tumors and (iv) Tests that predict response to systemic therapy in melanoma. This review will present an updated overview of major ancillary tests used in clinical practice. 相似文献
59.
Malinin Oleg V. Kiryanov Nikolay A. 《European journal of clinical microbiology & infectious diseases》2022,41(7):1059-1064
European Journal of Clinical Microbiology & Infectious Diseases - Hemorrhagic fever with renal syndrome (HFRS) continues to be a cause of death in Europe. Our aim was to describe the clinical... 相似文献